Entrez ID	Gene Symbol	Gene Name	Refseq mRNA	Refseq Protein	Ensembl Gene ID	UCSC Genomic Coordinates	GO Categories	Sources
324	APC	adenomatosis polyposis coli	NM_001127511, NM_001127510	NP_001120983.1, NP_001120982.1	ENSG00000134982	chr5:112118486 - 112207722	anterior/posterior pattern formation;axis specification;beta-catenin binding;beta-catenin destruction complex;cell adhesion;cell cycle;cell cycle arrest;centrosome;cytoplasm;dorsal/ventral pattern formation;kinetochore;lateral plasma membrane;microtubule binding;negative regulation of cell proliferation;negative regulation of cyclin-dependent protein kinase activity;negative regulation of microtubule depolymerization;nucleus;protein complex assembly;protein kinase binding;protein kinase CK2 regulator activi	Futreal et al 2004,  Hahn and Weinberg 2002,  Vogelstein and Kinzler 2004,  Protein Kinase,  Stability,  Tumor Suppressor,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
472	ATM	ataxia telangiectasia mutated (includes complementation groups A, C and D)	NM_138292, NM_000051	NP_612149.1, NP_000042.3	ENSG00000149311	chr11:107603561 - 107741445	1-phosphatidylinositol-3-kinase activity;cell cycle;DNA binding;DNA repair;meiotic recombination;mitotic spindle checkpoint;negative regulation of progression through cell cycle;nucleus;protein N-terminus binding;protein serine/threonine kinase activity;response to ionizing radiation;signal transduction;transferase activity	Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Protein Kinase,  Stability,  Tumor Suppressor,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
604	BCL6	B-cell CLL/lymphoma 6 (zinc finger protein 51)	NM_001706	NP_001697.2	ENSG00000113916	chr3:188922939 - 188934175	actin cytoskeleton organization and biogenesis;B cell differentiation;cell morphogenesis;chromatin binding;DNA binding;erythrocyte development;germinal center formation;intracellular;metal ion binding;negative regulation of B cell apoptosis;negative regulation of cell differentiation;negative regulation of cell growth;negative regulation of cell proliferation;negative regulation of cell-matrix adhesion;negative regulation of isotype switching to IgE isotypes;negative regulation of mast cell cytokine product	Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Entrez Query:Oncogene,  Missense mutation,  Translocation
641	BLM	Bloom syndrome	NM_000057	NP_000048.1	ENSG00000197299	chr15:89091626 - 89159513	ATP binding;ATP-dependent DNA helicase activity;DNA binding;DNA recombination;DNA repair;DNA replication;hydrolase activity;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;intracellular;nucleotide binding;nucleus;protein binding;regulation of binding;replication fork	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Protein Kinase,  Stability,  Tumor Suppressor,  Frameshift mutation,  Missense mutation,  Nonsense mutation
657	BMPR1A	bone morphogenetic protein receptor, type IA	NM_004329	NP_004320.2	ENSG00000107779	chr10:88625755 - 88673456	anterior/posterior pattern formation;ATP binding;cartilage development;cell differentiation;dorsal/ventral axis specification;ectoderm development;heart development;hindlimb morphogenesis;integral to membrane;lung development;magnesium ion binding;manganese ion binding;membrane;mesendoderm development;Mullerian duct regression;nucleotide binding;positive regulation of epithelial cell proliferation;protein amino acid phosphorylation;receptor activity;SMAD binding;transferase activity;transforming growth fact	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Tumor Suppressor,  Frameshift mutation,  Missense mutation,  Nonsense mutation
673	BRAF	v-raf murine sarcoma viral oncogene homolog B1	NM_004333	NP_004324.2	ENSG00000157764	chr7:140080865 - 140270972	anti-apoptosis;ATP binding;cytoplasm;diacylglycerol binding;intracellular signaling cascade;metal ion binding;nucleotide binding;organ morphogenesis;plasma membrane;protein amino acid phosphorylation;protein binding;protein serine/threonine kinase activity;receptor signaling protein activity;transferase activity;zinc ion binding	Futreal et al 2004,  Hahn and Weinberg 2002,  Vogelstein and Kinzler 2004,  Stability,  Tyrosine Kinase,  Entrez Query:Oncogene,  Missense mutation
672	BRCA1	breast cancer 1, early onset	NM_007298, NM_007300, NM_007303, NM_007299, NM_007294, NM_007302, NM_007304, NM_007305	NP_009229.1, NP_009231.1, NP_009234.1, NP_009230.1, NP_009227.1, NP_009228.1, NP_009235.2, NP_009236.1	ENSG00000012048	chr17:38451220 - 38529639	androgen receptor binding;androgen receptor signaling pathway;BRCA1-BARD1 complex;cell cycle;cell cycle checkpoint;cellular_component;chromosome segregation;DNA binding;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;DNA damage response, signal transduction resulting in induction of apoptosis;DNA repair;enzyme binding;fatty acid biosynthetic process;gamma-tubulin ring complex;intracellular;metal ion binding;molecular_function;negative regulatio	Futreal et al 2004,  Hahn and Weinberg 2002,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Entrez Query:Oncogene,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
675	BRCA2	breast cancer 2, early onset	NM_000059	NP_000050.2	ENSG00000139618	chr13:31788597 - 31870907	chromatin remodeling;cytoplasm;DNA repair;double-strand break repair via homologous recombination;establishment and/or maintenance of chromatin architecture;extracellular space;histone acetyltransferase activity;mitotic checkpoint;nucleus;protein binding;regulation of progression through cell cycle;regulation of S phase of mitotic cell cycle;regulation of transcription;secretory granule;single-stranded DNA binding;transcriptional activator activity	Futreal et al 2004,  Hahn and Weinberg 2002,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
701	BUB1B	BUB1 budding uninhibited by benzimidazoles 1 homolog beta (yeast)	NM_001211	NP_001202.4	ENSG00000156970	chr15:38240713 - 38300252	anaphase-promoting complex;apoptosis;ATP binding;cell cycle;cell division;cell proliferation;cytoplasm;kinetochore;mitosis;mitotic checkpoint;negative regulation of progression through cell cycle;nucleotide binding;nucleus;outer kinetochore of condensed chromosome;phosphoinositide-mediated signaling;protein amino acid phosphorylation;protein binding;protein serine/threonine kinase activity;spindle midzone;spindle organization and biogenesis;transferase activity	Futreal et al 2004,  Protein Kinase,  Stability,  Frameshift mutation,  Missense mutation,  Nonsense mutation,  Splicing mutation
999	CDH1	cadherin 1, type 1, E-cadherin (epithelial)	NM_004360	NP_004351.1	ENSG00000039068	chr16:67328819 - 67424903	calcium ion binding;cell adhesion;homophilic cell adhesion;integral to membrane;membrane;molecular_function;protein binding	Wnt,  Futreal et al 2004,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Frameshift mutation,  Missense mutation,  Nonsense mutation,  Splicing mutation
1019	CDK4	cyclin-dependent kinase 4	NM_000075	NP_000066.1	ENSG00000135446	chr12:56428574 - 56431767	ATP binding;cell cycle;cell division;cell proliferation;cyclin-dependent protein kinase activity;G1/S transition of mitotic cell cycle;nucleotide binding;nucleus;protein amino acid phosphorylation;protein binding;protein kinase activity;regulation of progression through cell cycle;transferase activity	TGFBR,  Futreal et al 2004,  Hahn and Weinberg 2002,  Vogelstein and Kinzler 2004,  Stability,  Missense mutation
1029	CDKN2A	cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)	NM_000077, NM_058197, NM_058195	NP_000068.1, NP_478104.2, NP_478102.1	ENSG00000147889	chr9:21961001 - 21984453	apoptosis;cell aging;cell cycle;cell cycle arrest;cell cycle checkpoint;cellular_component;cyclin-dependent protein kinase inhibitor activity;cytoplasm;DNA binding;epidermis development;negative regulation of cell proliferation;negative regulation of cyclin-dependent protein kinase activity;nucleolus;nucleoplasm;nucleus;protein binding;regulation of cyclin-dependent protein kinase activity;regulation of transcription, DNA-dependent;rRNA processing;transcription	Futreal et al 2004,  Hahn and Weinberg 2002,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Protein Kinase,  Stability,  Tumor Suppressor,  Entrez Query:Oncogene,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
1050	CEBPA	CCAAT/enhancer binding protein (C/EBP), alpha	NM_004364	NP_004355.2	null	chr19:38484083 - 38485160	cytokine and chemokine mediated signaling pathway;generation of precursor metabolites and energy;myeloid cell differentiation;nucleus;protein dimerization activity;regulation of transcription, DNA-dependent;RNA polymerase II transcription factor activity, enhancer binding;sequence-specific DNA binding;transcription;transcription factor binding;transcription from RNA polymerase II promoter	EGFR1,  Futreal et al 2004,  Tumor Suppressor,  Frameshift mutation,  Missense mutation,  Nonsense mutation
1499	CTNNB1	catenin (cadherin-associated protein), beta 1, 88kDa	NM_001904	NP_001895.1	ENSG00000168036	chr3:41240563 - 41255837	alpha-catenin binding;androgen receptor binding;androgen receptor signaling pathway;apical part of cell;basolateral plasma membrane;beta-catenin destruction complex;binding;bone resorption;cadherin binding;cell fate determination;cell fate specification;cell maturation;cell-cell adherens junction;cell-cell adhesion;cellular morphogenesis during differentiation;chromatin binding;cytoplasm;cytoskeleton;dorsal/ventral axis specification;ectoderm development;embryonic arm morphogenesis;embryonic digit morphogen	Androgen Receptor,  TGFBR,  Wnt,  Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Entrez Query:Oncogene,  Missense mutation
1540	CYLD	cylindromatosis (turban tumor syndrome)	NM_001042412, NM_015247	NP_001035877.1, NP_056062.1	ENSG00000083799	chr16:49341110 - 49387920	cell cycle;cysteine-type peptidase activity;cytoskeleton;intracellular;negative regulation of progression through cell cycle;ribosome;structural constituent of ribosome;translation;ubiquitin cycle;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process	TNF_alpha_NF_kB,  Futreal et al 2004,  Vogelstein and Kinzler 2004,  Tumor Suppressor,  Entrez Query:Oncogene,  Frameshift mutation,  Missense mutation,  Nonsense mutation,  Splicing mutation
1643	DDB2	damage-specific DNA binding protein 2, 48kDa	NM_000107	NP_000098.1	ENSG00000134574	chr11:47193263 - 47216976	damaged DNA binding;nucleotide-excision repair;nucleus;protein binding	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Stability,  Entrez Query:Oncogene,  Missense mutation,  Nonsense mutation
1956	EGFR	epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)	NM_201284, NM_005228, NM_201283, NM_201282	NP_958441.1, NP_005219.2, NP_958440.1, NP_958439.1	ENSG00000146648	chr7:55054464 - 55240804	actin filament binding;AP-2 adaptor complex;ATP binding;calcium-dependent phospholipase A2 activation;cell cycle;cell proliferation;cell surface receptor linked signal transduction;cell-cell adhesion;cytoplasm;double-stranded DNA binding;endosome;epidermal growth factor receptor activity;epidermal growth factor receptor signaling pathway;extracellular space;identical protein binding;integral to membrane;MAP/ERK kinase kinase activity;negative regulation of progression through cell cycle;nitric-oxide synthas	Alpha6Beta4 Integrin,  EGFR1,  Futreal et al 2004,  Vogelstein and Kinzler 2004,  Protein Kinase,  Stability,  Tumor Suppressor,  Tyrosine Kinase,  Entrez Query:Oncogene,  Amplification,  Missense mutation
2068	ERCC2	excision repair cross-complementing rodent repair deficiency, complementation group 2 (xeroderma pigmentosum D)	NM_000400	NP_000391.1	ENSG00000104884	chr19:50546726 - 50565638	5' to 3' DNA helicase activity;aging;ATP binding;ATP-dependent DNA helicase activity;DNA binding;holo TFIIH complex;hydrolase activity;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;induction of apoptosis;magnesium ion binding;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;nucleotide binding;nucleotide-excision repair;nucleus;post-embryonic development;protein binding;regulation of transcription, DNA-dependent;response to oxidative stress;sensory pe	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Protein Kinase,  Frameshift mutation,  Missense mutation,  Nonsense mutation,  Splicing mutation
2071	ERCC3	excision repair cross-complementing rodent repair deficiency, complementation group 3 (xeroderma pigmentosum group B complementing)	NM_000122	NP_000113.1	ENSG00000163161	chr2:127731641 - 127768127	3' to 5' DNA helicase activity;ATP binding;ATP-dependent DNA helicase activity;damaged DNA binding;DNA binding;DNA topological change;helicase activity;holo TFIIH complex;hydrolase activity;induction of apoptosis;nucleotide binding;nucleotide-excision repair;nucleus;regulation of transcription, DNA-dependent;sensory perception of sound;transcription;transcription factor binding;transcription from RNA polymerase II promoter;transcription-coupled nucleotide-excision repair	Futreal et al 2004,  Protein Kinase,  Stability,  Missense mutation,  Splicing mutation
2072	ERCC4	excision repair cross-complementing rodent repair deficiency, complementation group 4	NM_005236	NP_005227.1	ENSG00000175595	chr16:13921523 - 13949705	DNA binding;endodeoxyribonuclease activity;hydrolase activity;magnesium ion binding;nucleotide-excision repair;nucleotide-excision repair complex;nucleus	Futreal et al 2004,  Stability,  Frameshift mutation,  Missense mutation,  Nonsense mutation
2073	ERCC5	excision repair cross-complementing rodent repair deficiency, complementation group 5 (xeroderma pigmentosum, complementation group G (Cockayne syndrome))	NM_000123	NP_000114.2	ENSG00000134899	chr13:102257618 - 102322747	DNA binding;DNA repair;endodeoxyribonuclease activity;endonuclease activity;hydrolase activity;nuclease activity;nucleotide-excision repair;nucleus;sensory perception of sound;single-stranded DNA binding;transcription-coupled nucleotide-excision repair	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Frameshift mutation,  Missense mutation,  Nonsense mutation
2131	EXT1	exostoses (multiple) 1	NM_000127	NP_000118.2	ENSG00000182197	chr8:118881131 - 119192466	cell cycle;endoderm development;endoplasmic reticulum;endoplasmic reticulum membrane;gastrulation;glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity;glycosaminoglycan biosynthetic process;Golgi apparatus;heparan sulfate proteoglycan biosynthetic process;integral to endoplasmic reticulum membrane;integral to membrane;membrane;mesoderm development;N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity;negative regulation of progression through ce	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Tumor Suppressor,  Frameshift mutation,  Missense mutation,  Nonsense mutation,  Splicing mutation
2132	EXT2	exostoses (multiple) 2	NM_207122	NP_997005.1	ENSG00000151348	chr11:44085838 - 44222413	cell cycle;endoplasmic reticulum;endoplasmic reticulum membrane;glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity;glycosaminoglycan biosynthetic process;Golgi apparatus;integral to membrane;membrane;N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity;negative regulation of progression through cell cycle;protein binding;signal transduction;skeletal development;transferase activity, transferring glycosyl groups	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Tumor Suppressor,  Frameshift mutation,  Missense mutation,  Nonsense mutation,  Splicing mutation
2175	FANCA	Fanconi anemia, complementation group A	NM_001018112, NM_000135	NP_001018122.1, NP_000126.2	ENSG00000187741	chr16:88332509 - 88410524	cytoplasm;DNA repair;nucleus;protein binding;protein complex assembly	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Stability,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
2176	FANCC	Fanconi anemia, complementation group C	NM_000136	NP_000127.2	ENSG00000158169	chr9:96903809 - 97051394	cytoplasm;cytosol;DNA repair;germ cell development;nucleotide-excision repair;nucleus;protein binding;protein complex assembly	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Stability,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
2177	FANCD2	Fanconi anemia, complementation group D2	NM_001018115, NM_033084	NP_001018125.1, NP_149075.2	ENSG00000144554	chr3:10045341 - 10115634	biological_process;cell cycle;cellular_component;condensed chromosome;DNA repair;molecular_function;nucleus;protein binding	TNF_alpha_NF_kB,  Futreal et al 2004,  Vogelstein and Kinzler 2004,  Stability,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation
2189	FANCG	Fanconi anemia, complementation group G	NM_004629	NP_004620.1	ENSG00000165281	chr9:35064104 - 35069521	binding;cell cycle checkpoint;damaged DNA binding;DNA repair;nucleus;ovarian follicle development;response to radiation;spermatid development	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Stability,  Frameshift mutation,  Missense mutation,  Nonsense mutation,  Splicing mutation
355	FAS	Fas (TNF receptor superfamily, member 6)	NM_152875, NM_152877, NM_000043, NM_152872, NM_152874, NM_152871, NM_152876	NP_690614.1, NP_690616.1, NP_000034.1, NP_690611.1, NP_690613.1, NP_690610.1, NP_690615.1	ENSG00000026103	chr10:90740613 - 90764187	anti-apoptosis;apoptosis;cytosol;identical protein binding;immune response;induction of apoptosis;integral to membrane;membrane;protein binding;protein complex assembly;regulation of apoptosis;signal transduction;soluble fraction;transmembrane receptor activity	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Tumor Suppressor,  Missense mutation
55294	FBXW7	F-box and WD repeat domain containing 7	NM_001013415, NM_033632, NM_018315	NP_001013433.1, NP_361014.1, NP_060785.2	ENSG00000109670	chr4:153463482 - 153552405	nucleus;protein binding;protein ubiquitination	NOTCH,  Futreal et al 2004,  Vogelstein and Kinzler 2004,  Tumor Suppressor,  Missense mutation,  Nonsense mutation
2263	FGFR2	fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome)	NM_000141, NM_022970	NP_000132.3, NP_075259.4	ENSG00000066468	chr10:123229360 - 123343321	ATP binding;cell growth;cell surface;fibroblast growth factor receptor activity;heparin binding;integral to membrane;membrane;nucleotide binding;protein amino acid phosphorylation;protein binding;protein-tyrosine kinase activity;receptor activity;transferase activity	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Protein Kinase,  Stability,  Tyrosine Kinase,  Entrez Query:Oncogene,  Missense mutation
2261	FGFR3	fibroblast growth factor receptor 3 (achondroplasia, thanatophoric dwarfism)	NM_022965, NM_000142	NP_075254.1, NP_000133.1	ENSG00000068078	chr4:1765459 - 1778787	ATP binding;cell growth;fibroblast growth factor receptor activity;fibroblast growth factor receptor signaling pathway;identical protein binding;integral to plasma membrane;JAK-STAT cascade;MAPKKK cascade;membrane;nucleotide binding;protein amino acid phosphorylation;protein-tyrosine kinase activity;receptor activity;skeletal development;transferase activity	Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Tyrosine Kinase,  Missense mutation,  Translocation
2271	FH	fumarate hydratase	NM_000143	NP_000134.2	ENSG00000091483	chr1:239727750 - 239749645	cell cycle;cytoplasm;fumarate hydratase activity;fumarate metabolic process;lyase activity;mitochondrion;negative regulation of progression through cell cycle;tricarboxylic acid cycle;tricarboxylic acid cycle enzyme complex	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Tumor Suppressor,  Frameshift mutation,  Missense mutation,  Nonsense mutation
201163	FLCN	folliculin	NM_144606, NM_144997	NP_653207.1, NP_659434.2	ENSG00000154803	chr17:17057693 - 17072176	cell cycle;negative regulation of progression through cell cycle	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Tumor Suppressor,  Frameshift mutation,  Missense mutation,  Nonsense mutation
2322	FLT3	fms-related tyrosine kinase 3	NM_004119	NP_004110.2	ENSG00000122025	chr13:27476188 - 27572647	ATP binding;integral to plasma membrane;lymphocyte differentiation;membrane;nucleotide binding;positive regulation of cell proliferation;protein amino acid phosphorylation;protein binding;receptor activity;transferase activity;transmembrane receptor protein tyrosine kinase signaling pathway;vascular endothelial growth factor receptor activity	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Protein Kinase,  Tumor Suppressor,  Tyrosine Kinase,  Missense mutation
2324	FLT4	fms-related tyrosine kinase 4	NM_182925, NM_002020	NP_891555.2, NP_002011.2	ENSG00000037280	chr5:179962797 - 180009151	ATP binding;integral to plasma membrane;membrane;nucleotide binding;protein amino acid phosphorylation;protein binding;protein-tyrosine kinase activity;receptor activity;transferase activity;transmembrane receptor protein tyrosine kinase signaling pathway;vascular endothelial growth factor receptor activity	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Protein Kinase,  Tyrosine Kinase,  Missense mutation
2623	GATA1	GATA binding protein 1 (globin transcription factor 1)	NM_002049	NP_002040.1	ENSG00000102145	chrX:48534460 - 48537515	metal ion binding;multicellular organismal development;nucleus;regulation of transcription from RNA polymerase II promoter;sequence-specific DNA binding;transcription;transcription factor activity;zinc ion binding	NOTCH,  Futreal et al 2004,  Frameshift mutation,  Missense mutation
2778	GNAS	GNAS complex locus	NM_080426, NM_001077489, NM_001077488, NM_000516, NM_080425, NM_016592	NP_536351.1, NP_001070957.1, NP_001070956.1, NP_000507.1, NP_536350.2, NP_057676.1	ENSG00000087460	chr20:56861715 - 56919279	adenylate cyclase activation;cytoplasm;extracellular region;G-protein coupled receptor protein signaling pathway;G-protein signaling, adenylate cyclase activating pathway;Golgi to secretory vesicle transport;Golgi trans cisterna;GTP binding;GTPase activity;guanyl nucleotide binding;heterotrimeric G-protein complex;membrane;molecular_function;nucleotide binding;plasma membrane;pregnancy;protein binding;protein secretion;protein targeting;sensory perception of smell;signal transducer activity;signal transduct	Futreal et al 2004,  Missense mutation
2719	GPC3	glypican 3	NM_004484	NP_004475.1	ENSG00000147257	chrX:132497817 - 132947142	GPI anchor binding;integral to plasma membrane;membrane;negative regulation of cell proliferation;negative regulation of growth;organ morphogenesis;positive regulation of BMP signaling pathway;proteinaceous extracellular matrix;ureteric bud branching	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Tumor Suppressor,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation,  Translocation
6927	HNF1A	transcription factor 1, hepatic; LF-B1, hepatic nuclear factor (HNF1), albumin proximal factor	NM_000545	NP_000536.4	ENSG00000135100	chr12:119900954 - 119923378	glucose homeostasis;nucleus;positive regulation of transcription;protein binding;regulation of transcription from RNA polymerase II promoter;RNA polymerase II transcription factor activity;sequence-specific DNA binding;transcription factor activity;transcriptional activator activity	Futreal et al 2004,  Stability,  Frameshift mutation,  Missense mutation
3265	HRAS	v-Ha-ras Harvey rat sarcoma viral oncogene homolog	NM_176795, NM_005343	NP_789765.1, NP_005334.1	ENSG00000174775	chr11:522635 - 524322	cell surface receptor linked signal transduction;chemotaxis;cytoplasm;GTP binding;intracellular;membrane;nucleotide binding;organ morphogenesis;plasma membrane;protein C-terminus binding;regulation of progression through cell cycle;small GTPase mediated signal transduction	EGFR1,  Kit Receptor,  Futreal et al 2004,  Hahn and Weinberg 2002,  Tumor Suppressor,  Entrez Query:Oncogene,  Missense mutation
3815	KIT	v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog	NM_000222, NM_001093772	NP_000213.1, NP_001087241.1	ENSG00000157404	chr4:55218938 - 55299480	ATP binding;cytokine and chemokine mediated signaling pathway;external side of plasma membrane;hemopoiesis;integral to membrane;membrane;nucleotide binding;peptidyl-tyrosine phosphorylation;pigmentation during development;protein amino acid dephosphorylation;protein binding;protein kinase cascade;receptor activity;receptor signaling protein tyrosine kinase activity;response to radiation;signal transduction;stem cell factor receptor activity;transferase activity;transmembrane receptor protein tyrosine kinase	Kit Receptor,  Futreal et al 2004,  Vogelstein and Kinzler 2004,  Protein Kinase,  Tumor Suppressor,  Tyrosine Kinase,  Entrez Query:Oncogene,  Missense mutation
1316	KLF6	Kruppel-like factor 6	NM_001300	NP_001291.3	ENSG00000067082	chr10:3811730 - 3817206	B cell differentiation;biological_process;cell growth;cellular_component;DNA binding;intracellular;metal ion binding;molecular_function;nucleic acid binding;nucleus;regulation of transcription, DNA-dependent;transcription;transcriptional activator activity;zinc ion binding	Futreal et al 2004,  Stability,  Tumor Suppressor,  Entrez Query:Oncogene,  Missense mutation,  Nonsense mutation
3845	KRAS	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog	NM_004985, NM_033360	NP_004976.2, NP_203524.1	ENSG00000133703	chr12:25259641 - 25289585	GTP binding;GTPase activity;intracellular;membrane;nucleotide binding;protein binding;regulation of progression through cell cycle;sensory perception of sound;small GTPase mediated signal transduction	EGFR1,  Futreal et al 2004,  Vogelstein and Kinzler 2004,  Tumor Suppressor,  Entrez Query:Oncogene,  Missense mutation
6416	MAP2K4	mitogen-activated protein kinase kinase 4	NM_003010	NP_003001.1	ENSG00000065559	chr17:11864928 - 11985302	ATP binding;JNK cascade;nucleotide binding;protein amino acid phosphorylation;protein binding;protein serine/threonine kinase activity;protein-tyrosine kinase activity;signal transduction;transferase activity	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Tumor Suppressor,  Large deletion,  Missense mutation,  Nonsense mutation
4221	MEN1	multiple endocrine neoplasia I	NM_130802, NM_130799	NP_570716.1, NP_570711.1	ENSG00000133895	chr11:64328381 - 64334157	cleavage furrow;cytosol;DNA binding;histone methylation;histone methyltransferase complex;negative regulation of transcription from RNA polymerase II promoter;nucleus;positive regulation of transcription;protein binding;regulation of transcription, DNA-dependent;transcription regulator activity	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Protein Kinase,  Stability,  Tumor Suppressor,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
4233	MET	met proto-oncogene (hepatocyte growth factor receptor)	NM_001127500, NM_000245	NP_001120972.1, NP_000236.2	ENSG00000105976	chr7:116126374 - 116223414	activation of MAPK activity;adult behavior;ATP binding;basal plasma membrane;brain development;cell surface receptor linked signal transduction;hepatocyte growth factor receptor activity;hepatocyte growth factor receptor signaling pathway;integral to plasma membrane;membrane;membrane fraction;multicellular organismal development;muscle development;myoblast proliferation;nucleotide binding;protein amino acid autophosphorylation;protein amino acid phosphorylation;protein binding;protein-tyrosine kinase activi	Alpha6Beta4 Integrin,  Futreal et al 2004,  Vogelstein and Kinzler 2004,  Protein Kinase,  Stability,  Tumor Suppressor,  Tyrosine Kinase,  Entrez Query:Oncogene,  Missense mutation
4292	MLH1	mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli)	NM_000249	NP_000240.1	ENSG00000076242	chr3:37010042 - 37067148	ATP binding;cell cycle;guanine/thymine mispair binding;mismatch repair;mismatched DNA binding;MutSalpha complex binding;negative regulation of progression through cell cycle;nucleus;protein binding;single-stranded DNA binding	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
4436	MSH2	mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli)	NM_000251	NP_000242.1	ENSG00000095002	chr2:47483834 - 47563592	ADP binding;apoptosis;ATP binding;ATPase activity;B cell differentiation;B cell mediated immunity;base-excision repair;cell cycle;cell cycle arrest;cell motility;centromeric DNA binding;damaged DNA binding;determination of adult life span;dinucleotide repeat insertion binding;four-way junction DNA binding;guanine/thymine mispair binding;hypoxanthine phosphoribosyltransferase activity;in utero embryonic development;intra-S DNA damage checkpoint;isotype switching;magnesium ion binding;maintenance of DNA repea	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
2956	MSH6	mutS homolog 6 (E. coli)	NM_000179	NP_000170.1	ENSG00000116062	chr2:47863876 - 47887503	ADP binding;ATP binding;ATPase activity;base-excision repair;chromatin binding;damaged DNA binding;determination of adult life span;dinucleotide insertion or deletion binding;DNA damage response, signal transduction resulting in induction of apoptosis;four-way junction DNA binding;guanine/thymine mispair binding;isotype switching;magnesium ion binding;mismatch repair;mismatched DNA binding;MutLalpha complex binding;MutSalpha complex;negative regulation of DNA recombination;nuclear chromatin;nucleotide bindi	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Stability,  Frameshift mutation,  Missense mutation,  Nonsense mutation,  Splicing mutation
4595	MUTYH	mutY homolog (E. coli)	NM_001048172, NM_001128425, NM_001048173, NM_012222	NP_001041637.1, NP_001121897.1, NP_001041639.1, NP_036354.1	ENSG00000132781	chr1:45567564 - 45572764	4 iron, 4 sulfur cluster binding;base-excision repair;cell cycle;DNA binding;DNA N-glycosylase activity;endonuclease activity;hydrolase activity;hydrolase activity, acting on glycosyl bonds;intracellular;iron ion binding;metabolic process;metal ion binding;mismatch repair;MutLalpha complex binding;MutLbeta complex binding;MutSalpha complex binding;MutSbeta complex binding;negative regulation of progression through cell cycle;nucleus;protein binding	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Stability,  Missense mutation
4683	NBN	nibrin			ENSG00000104320	chr8:null	blastocyst growth;cell cycle;cell cycle arrest;cell proliferation;chromosome;chromosome, telomeric region;damaged DNA binding;DNA damage checkpoint;DNA damage response, signal transduction by p53 class mediator;double-strand break repair;G1/S transition checkpoint;in utero embryonic development;intracellular;isotype switching;meiosis;mitotic G2 checkpoint;Mre11 complex;nuclear inclusion body;nucleus;protein N-terminus binding;regulation of balance;regulation of DNA replication initiation;replication fork;te	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Frameshift mutation,  Missense mutation,  Nonsense mutation
4763	NF1	neurofibromin 1 (neurofibromatosis, von Recklinghausen disease, Watson disease)	NM_000267, NM_001042492, NM_001128147	NP_000258.1, NP_001035957.1, NP_001121619.1	ENSG00000196712	chr17:26446453 - 26725299	adrenal gland development;biological_process;cell cycle;cellular_component;cytoplasm;enzyme inhibitor activity;GTPase activator activity;heart development;intracellular;molecular_function;negative regulation of cell migration;negative regulation of endothelial cell proliferation;negative regulation of MAPKKK cascade;negative regulation of progression through cell cycle;positive regulation of Ras GTPase activity;protein binding;Ras GTPase activator activity;Ras protein signal transduction;regulation of glial	Futreal et al 2004,  Hahn and Weinberg 2002,  Vogelstein and Kinzler 2004,  Tumor Suppressor,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
4771	NF2	neurofibromin 2 (bilateral acoustic neuroma)	NM_181832, NM_000268, NM_181828, NM_181829, NM_181833, NM_181830	NP_861970.1, NP_000259.1, NP_861966.1, NP_861967.1, NP_861971.1, NP_861969.1	ENSG00000186575	chr22:28329987 - 28420791	cell cycle;cytoplasm;cytoskeletal protein binding;cytoskeleton;negative regulation of cell proliferation;negative regulation of progression through cell cycle;nucleus;plasma membrane;sensory perception of sound;structural molecule activity	Futreal et al 2004,  Hahn and Weinberg 2002,  Vogelstein and Kinzler 2004,  Protein Kinase,  Tumor Suppressor,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
4851	NOTCH1	Notch homolog 1, translocation-associated (Drosophila)	NM_017617	NP_060087.3	null	chr9:138510343 - 138560059	calcium ion binding;cell differentiation;immune response;integral to membrane;membrane;multicellular organismal development;negative regulation of myoblast differentiation;Notch signaling pathway;nucleus;protein binding;receptor activity;regulation of developmental process;regulation of transcription, DNA-dependent	NOTCH,  Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Missense mutation,  Translocation
4893	NRAS	neuroblastoma RAS viral (v-ras) oncogene homolog	NM_002524	NP_002515.1	ENSG00000168638	chr1:115052678 - 115060304	GTP binding;GTPase activity;intracellular;membrane;nucleotide binding;regulation of progression through cell cycle;small GTPase mediated signal transduction	EGFR1,  Futreal et al 2004,  Hahn and Weinberg 2002,  Entrez Query:Oncogene,  Missense mutation
5156	PDGFRA	platelet-derived growth factor receptor, alpha polypeptide	NM_006206	NP_006197.1	ENSG00000134853	chr4:54819692 - 54856196	ATP binding;cell proliferation;cell surface receptor linked signal transduction;extracellular matrix organization and biogenesis;integral to plasma membrane;lung development;male genitalia development;membrane;nucleotide binding;odontogenesis (sensu Vertebrata);organ morphogenesis;platelet-derived growth factor alpha-receptor activity;platelet-derived growth factor binding;protein amino acid phosphorylation;receptor activity;transferase activity;transmembrane receptor protein tyrosine kinase signaling pathw	Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Tyrosine Kinase,  Missense mutation,  Translocation
8929	PHOX2B	paired-like homeobox 2b	NM_003924	NP_003915.2	ENSG00000109132	chr4:41442580 - 41445384	cell development;multicellular organismal development;nervous system development;nucleus;regulation of transcription, DNA-dependent;sequence-specific DNA binding;transcription cofactor activity;transcription factor activity	Futreal et al 2004,  Frameshift mutation,  Missense mutation
5290	PIK3CA	phosphoinositide-3-kinase, catalytic, alpha polypeptide	NM_006218	NP_006209.2	ENSG00000121879	chr3:180399307 - 180434846	1-phosphatidylinositol-3-kinase activity;anti-apoptosis;glucose metabolic process;inositol or phosphatidylinositol kinase activity;insulin receptor substrate binding;lamellipodium;phosphatidylinositol-4,5-bisphosphate 3-kinase activity;phosphoinositide 3-kinase complex;protein amino acid phosphorylation;protein kinase B signaling cascade;regulation of body size;signal transduction;transferase activity	Alpha6Beta4 Integrin,  EGFR1,  Futreal et al 2004,  Hahn and Weinberg 2002,  Tumor Suppressor,  Entrez Query:Oncogene,  Missense mutation
5378	PMS1	PMS1 postmeiotic segregation increased 1 (S. cerevisiae)	NM_000534, NM_001128143, NM_001128144	NP_000525.1, NP_001121615.1, NP_001121616.1	ENSG00000064933	chr2:190364780 - 190450407	ATP binding;cell cycle;DNA binding;GTP binding;mismatch repair;mismatched DNA binding;negative regulation of progression through cell cycle;nucleotide binding;nucleus;regulation of transcription, DNA-dependent	Futreal et al 2004,  Missense mutation,  Nonsense mutation
5395	PMS2	PMS2 postmeiotic segregation increased 2 (S. cerevisiae)	NM_000535	NP_000526.1	ENSG00000122512	chr7:5979555 - 6015176	ATP binding;cell cycle;DNA binding;mismatch repair;mismatched DNA binding;MutSalpha complex binding;negative regulation of progression through cell cycle;nucleus;protein binding;single base insertion or deletion binding;single-stranded DNA binding	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Frameshift mutation,  Missense mutation,  Nonsense mutation
5573	PRKAR1A	protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1)	NM_002734	NP_997637.1	ENSG00000108946	chr17:64023135 - 64038185	cAMP binding;cAMP-dependent protein kinase complex;cAMP-dependent protein kinase regulator activity;intracellular signaling cascade;kinase activity;mesoderm formation;neuromuscular junction;nucleotide binding;protein amino acid phosphorylation;protein binding;regulation of transcription from RNA polymerase II promoter;signal transduction	Futreal et al 2004,  Mitelman 2000,  Tumor Suppressor,  Entrez Query:Oncogene,  Frameshift mutation,  Missense mutation,  Nonsense mutation,  Splicing mutation,  Translocation
5727	PTCH1	patched homolog 1 (Drosophila)	NM_000264, NM_001083602, NM_001083603	NP_001077076.1, NP_001077071.1, NP_001077072.1	ENSG00000185920	chr9:97249014 - 97310464	cell cycle;cell proliferation;dorsal/ventral pattern formation;embryonic limb morphogenesis;hedgehog receptor activity;integral to membrane;integral to plasma membrane;membrane;negative regulation of body size;negative regulation of progression through cell cycle;organ morphogenesis;protein binding;protein processing;receptor activity;regulation of smoothened activity;signal transduction;smoothened signaling pathway	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Tumor Suppressor,  Frameshift mutation,  Missense mutation,  Nonsense mutation,  Splicing mutation
5728	PTEN	phosphatase and tensin homolog (mutated in multiple advanced cancers 1)	NM_000314	NP_000305.3	ENSG00000171862	chr10:89614206 - 89715209	cell cycle;cell migration;cell proliferation;central nervous system development;cytoplasm;heart development;hydrolase activity;induction of apoptosis;inositol phosphate dephosphorylation;inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity;lipid binding;lipid metabolic process;negative regulation of apoptosis;negative regulation of cell migration;negative regulation of cell proliferation;negative regulation of focal adhesion formation;negative regulation of progression through cell cycle;negative regul	Androgen Receptor,  Futreal et al 2004,  Hahn and Weinberg 2002,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Entrez Query:Oncogene,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
5781	PTPN11	protein tyrosine phosphatase, non-receptor type 11 (Noonan syndrome 1)	NM_002834	NP_002825.3	ENSG00000179295	chr12:111341298 - 111426951	hydrolase activity;intracellular signaling cascade;non-membrane spanning protein tyrosine phosphatase activity;protein amino acid dephosphorylation;protein binding;sensory perception of sound	EGFR1,  Kit Receptor,  TNF_alpha_NF_kB,  Futreal et al 2004,  Phosphatase,  Stability,  Entrez Query:Oncogene,  Missense mutation
5925	RB1	retinoblastoma 1 (including osteosarcoma)	NM_000321	NP_000312.2	ENSG00000139687	chr13:47776049 - 47952208	androgen receptor binding;androgen receptor signaling pathway;cell cycle;cell cycle checkpoint;chromatin;chromatin modification;G1 phase;kinase binding;M phase;molecular_function;negative regulation of cell growth;negative regulation of progression through cell cycle;negative regulation of protein kinase activity;negative regulation of transcription from RNA polymerase II promoter;nucleus;PML body;positive regulation of transcription, DNA-dependent;protein binding;regulation of lipid kinase activity;regulat	Androgen Receptor,  ID,  TGFBR,  Futreal et al 2004,  Hahn and Weinberg 2002,  Vogelstein and Kinzler 2004,  Protein Kinase,  Stability,  Tumor Suppressor,  Entrez Query:Oncogene,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
5979	RET	ret proto-oncogene	NM_020630, NM_020975	NP_065681.1, NP_066124.1	ENSG00000165731	chr10:42892712 - 42943723	ATP binding;calcium ion binding;cell surface receptor linked signal transduction;homophilic cell adhesion;integral to membrane;kinase activity;membrane;nucleotide binding;posterior midgut development;protein amino acid phosphorylation;protein-tyrosine kinase activity;receptor activity;signal transduction;transferase activity	Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Protein Kinase,  Stability,  Tumor Suppressor,  Tyrosine Kinase,  Entrez Query:Oncogene,  Frameshift mutation,  Missense mutation,  Nonsense mutation,  Translocation
6390	SDHB	succinate dehydrogenase complex, subunit B, iron sulfur (Ip)	NM_003000	NP_002991.2	ENSG00000117118	chr1:17217962 - 17253101	2 iron, 2 sulfur cluster binding;3 iron, 4 sulfur cluster binding;4 iron, 4 sulfur cluster binding;electron carrier activity;electron transport;iron ion binding;membrane;metal ion binding;mitochondrial inner membrane;mitochondrion;succinate dehydrogenase (ubiquinone) activity;transport;tricarboxylic acid cycle	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Tumor Suppressor,  Frameshift mutation,  Missense mutation,  Nonsense mutation
6391	SDHC	succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa	NM_001089593, NM_001035513, NM_003001, NM_001035511	NP_001083062.1, NP_001030590.1, NP_002992.1, NP_001030588.1	ENSG00000143252	chr1:159550819 - 159598847	electron transport;integral to membrane;iron ion binding;membrane;metal ion binding;mitochondrion;respiratory chain complex II;succinate dehydrogenase activity;transport;tricarboxylic acid cycle	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Frameshift mutation,  Missense mutation,  Nonsense mutation
6392	SDHD	succinate dehydrogenase complex, subunit D, integral membrane protein	NM_003002	NP_002993.1	null	chr11:111462841 - 111470904	electron carrier activity;electron transport;heme binding;integral to membrane;iron ion binding;membrane;metal ion binding;mitochondrial envelope;mitochondrial inner membrane;mitochondrion;succinate dehydrogenase activity;transport;tricarboxylic acid cycle	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Tumor Suppressor,  Frameshift mutation,  Missense mutation,  Nonsense mutation,  Splicing mutation
4089	SMAD4	SMAD family member 4	NM_005359	NP_005350.1	ENSG00000141646	chr18:46827414 - 46858835	anterior/posterior pattern formation;cytoplasm;gastrulation (sensu Mammalia);intracellular;kidney development;negative regulation of cell proliferation;nucleus;positive regulation of transcription from RNA polymerase II promoter;protein binding;regulation of binding;SMAD protein complex assembly;transcription;transcription cofactor activity;transcription factor activity;transcription factor complex;transcriptional activator activity;ureteric bud branching	Androgen Receptor,  NOTCH,  TGFBR,  Wnt,  Futreal et al 2004,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation
6608	SMO	smoothened homolog (Drosophila)	NM_005631	NP_005622.1	ENSG00000128602	chr7:128616228 - 128639528	cell development;central nervous system neuron differentiation;cerebellar cortex morphogenesis;cilium;determination of left/right symmetry;developmental growth;dorsal/ventral pattern formation;G-protein coupled receptor activity;G-protein coupled receptor protein signaling pathway;integral to membrane;membrane;membrane fraction;negative regulation of apoptosis;negative regulation of DNA binding;non-G-protein coupled 7TM receptor activity;odontogenesis (sensu Vertebrata);osteoblast differentiation;pattern sp	Hedgehog,  Futreal et al 2004,  Tumor Suppressor,  Entrez Query:Oncogene,  Missense mutation
6794	STK11	serine/threonine kinase 11	NM_000455	NP_000446.1	ENSG00000118046	chr19:1157912 - 1177646	ATP binding;cell cycle;cell cycle arrest;cytoplasm;magnesium ion binding;manganese ion binding;nucleotide binding;nucleus;protein amino acid phosphorylation;protein binding;protein serine/threonine kinase activity;transferase activity	TGFBR,  Futreal et al 2004,  Vogelstein and Kinzler 2004,  Protein Kinase,  Tumor Suppressor,  Entrez Query:Oncogene,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
7157	TP53	tumor protein p53 (Li-Fraumeni syndrome)	NM_001126114, NM_001126117, NM_000546, NM_001126113, NM_001126112, NM_001126116	NP_001119586.1, NP_001119589.1, NP_001119587.1, NP_001119585.1, NP_001119584.1, NP_001119588.1	ENSG00000141510	chr17:7513651 - 7520637	ATP binding;base-excision repair;caspase activation via cytochrome c;cell aging;cell cycle;cell cycle arrest;cell differentiation;cell proliferation;cellular response to glucose starvation;copper ion binding;cytoplasm;DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis;DNA strand annealing activity;endoplasmic reticulum;enzyme binding;ER overload response;induction of apoptosis by intracellular signals;insoluble fraction;metal ion binding;mitochondrion;multicel	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Entrez Query:Oncogene,  Frameshift mutation,  Missense mutation,  Nonsense mutation
7248	TSC1	tuberous sclerosis 1	NM_000368, NM_001008567	NP_000359.1, NP_001008567.1	ENSG00000165699	chr9:134761442 - 134794080	cell adhesion;cell cycle;negative regulation of progression through cell cycle;Rho protein signal transduction	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Protein Kinase,  Tumor Suppressor,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
7249	TSC2	tuberous sclerosis 2	NM_001114382, NM_001077183, NM_000548	NP_001107854.1, NP_001070651.1, NP_000539.2	ENSG00000103197	chr16:2038617 - 2078612	cell cycle;cytoplasm;cytosol;endocytosis;GTPase activator activity;intracellular;membrane fraction;negative regulation of progression through cell cycle;plasma membrane;positive regulation of GTPase activity;protein folding;regulation of small GTPase mediated signal transduction;unfolded protein binding	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Protein Kinase,  Stability,  Tumor Suppressor,  Entrez Query:Oncogene,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
7253	TSHR	thyroid stimulating hormone receptor	NM_001018036, NM_000369	NP_001018046.1, NP_000360.2	ENSG00000165409	chr14:80491777 - 80680450	adult locomotory behavior;cell-cell signaling;G-protein coupled receptor protein signaling pathway;G-protein signaling, adenylate cyclase activating pathway;G-protein signaling, coupled to cyclic nucleotide second messenger;integral to membrane;integral to plasma membrane;membrane;plasma membrane;positive regulation of body size;positive regulation of cell proliferation;protein binding;protein-hormone receptor activity;receptor activity;regulation of locomotion;signal transduction;thyroid-stimulating hormon	Futreal et al 2004,  Missense mutation
7428	VHL	von Hippel-Lindau tumor suppressor	NM_198156, NM_000551	NP_937799.1, NP_000542.1	ENSG00000134086	chr3:10158531 - 10166649	anti-apoptosis;cell cycle;cell morphogenesis;cytosol;endoplasmic reticulum;mitochondrion;negative regulation of cell proliferation;negative regulation of progression through cell cycle;negative regulation of transcription from RNA polymerase II promoter;nucleus;positive regulation of cell differentiation;protein stabilization;protein ubiquitination;proteolysis;response to stress;transcription factor binding	Futreal et al 2004,  Hahn and Weinberg 2002,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
7454	WAS	Wiskott-Aldrich syndrome (eczema-thrombocytopenia)	NM_000377	NP_000368.1	ENSG00000015285	chrX:48427186 - 48434497	actin cytoskeleton;actin filament polymerization;actin filament-based movement;blood coagulation;defense response;endosome transport;epidermis development;identical protein binding;immune response;protein complex assembly;small GTPase regulator activity;T cell activation;vesicle membrane	Futreal et al 2004,  Frameshift mutation,  Missense mutation,  Nonsense mutation,  Splicing mutation
7486	WRN	Werner syndrome	NM_000553	NP_000544.2	ENSG00000165392	chr8:31035505 - 31150160	3'-5' exonuclease activity;aging;ATP binding;ATP-dependent helicase activity;DNA binding;DNA helicase activity;DNA recombination;hydrolase activity;intracellular;nucleotide binding;nucleus;protein binding;regulation of growth rate;telomere maintenance	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Frameshift mutation,  Missense mutation,  Nonsense mutation,  Splicing mutation
7490	WT1	Wilms tumor 1	NM_000378, NM_024424, NM_024426, NM_024425	NP_000369.3, NP_077742.2, NP_077744.3, NP_077743.2	ENSG00000184937	chr11:32367179 - 32413467	cell cycle;intracellular;metal ion binding;negative regulation of progression through cell cycle;nucleic acid binding;nucleus;regulation of transcription, DNA-dependent;transcription;transcription factor activity;zinc ion binding	Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Tumor Suppressor,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
7507	XPA	xeroderma pigmentosum, complementation group A	NM_000380	NP_000371.1	ENSG00000136936	chr9:99477541 - 99499395	damaged DNA binding;metal ion binding;nucleotide-excision repair;nucleus;protein binding;zinc ion binding	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Stability,  Frameshift mutation,  Missense mutation,  Nonsense mutation,  Splicing mutation
7508	XPC	xeroderma pigmentosum, complementation group C	NM_004628	NP_004619.3	ENSG00000154767	chr3:14162441 - 14195072	damaged DNA binding;nucleotide-excision repair;nucleus;protein binding;single-stranded DNA binding	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Stability,  Frameshift mutation,  Missense mutation,  Nonsense mutation,  Splicing mutation
